Study of substrate specificity of a new peptide substrate of endothelin converting enzyme

   


1. Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences
Type: Experimental/clinical study
UDK: 577.152.341*51      PubMed Id: 17639718
Year: 2007 vol: 53  issue:2  pages: 172-180
Abstract: The new fluorogenic hexapeptide substrate CMC-Ala-Gly-Gly-Trp-Phe-Arg was used as substrate for endothelin-converting enzyme (ECE), angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP). The specific inhibitors lisinopril (ACE) and thiorphan (NEP) were used for identification of these enzyme activities.
Download PDF:
Reference: Gureeva T.A., Kugaevskaya Е.V., Pozdnev V.F., Prozorovskiy V.N., Elisseeva Yu.Е., Solovyeva N.I., Study of substrate specificity of a new peptide substrate of endothelin converting enzyme, Biomeditsinskaya khimiya, 2007, vol: 53(2), 172-180.
Bibliography
 2016(Vol:62)
 2015(Vol:61)
 2014(Vol:60)
 2013(Vol:59)
 2012(Vol:58)
 2011(Vol:57)
 2010(Vol:56)
 2009(Vol:55)
 2008(Vol:54)
 2007(Vol:53)
 2006(Vol:52)
 2005(Vol:51)
 2004(Vol:50)
 2003(Vol:49)